Product variation is a natural effect of manufacturing, the question here is how do you manage product variation in a manner that can improve your business and meet customer specifications.
The Answer:Automating the customer specification and product regrading process.This is especially important for organisations that cater to a wide range of customers or export markets that may have different specifications due to preferences or government/industry regulations.
During the COVID-19 pandemic, the world has developed a renewed interest in, and placed an emphasis on, diagnostics. As a result, new companies and laboratories are being established across the U.S. to support the need for diagnostic testing. In some cases, companies are building brand new facilities from the ground up, while others are setting up diagnostic workflows in biotechnology incubators or other pre-existing laboratory infrastructures.
In what is planned to be an ever-growing resource for laboratory informatics professionals everywhere, CSols, Inc., the premier laboratory informatics consultancy, has launched CSols University, with its first-ever online course, Creating a Lab Informatics Risk Assessment. This one-hour course is the first to launch this summer, with more to come in the near future.
Encoded Therapeutics Inc. (Encoded), a biotechnology company advancing precision medicines for a broad range of genetic disorders. With the increasing need to establish a harmonized laboratory data and process workflow to support the rapid growth of the company, Encoded Therapeutics chose Astrix Technology Group to develop their Informatics Roadmap and Sample Management strategy. However, the COVID-19 pandemic would require a novel new approach to doing business in an unprecedented remote work environment.
LabLynx, Inc. today announced an important new component in its overall COVIDLiMS informatics solution for laboratories, designed to offer faster, more accurate coronavirus testing as well as ongoing risk management for businesses and organizations. The C-SIC (COVID-Sample Information Collection) kit accurately captures specimen and patient information and ensures it is included on the sample label, preventing errors during sampling and transport.
In this 2020 paper published in the journal Toxins, Di Nardo et al. of the University of Turin present their findings from adapting an existing enzyme immunoassay to cannabis testing for purposes of more accurately detecting mycotoxins, including aflatoxins such as aflatoxin B1 (AFB1). Citing benefits such as fewer steps, more cost-efficient equipment, and fewer training level demands, the authors viewed the application of enzyme immunoassay to testing cannabis for mycotoxins a worthy endeavor. Di Nardo et al. discuss at length how they converted an immunoassay for measuring aflatoxins in eggs to one for the cannabis substrate, as well as the various challenges and caveats associated with the resulting methodology. In comparison to techniques such as ultra-high performance liquid chromatography coupled to high resolution tandem mass spectrometry, the authors concluded that enzyme immunoassay more readily allows for "wide applications in low resource settings and for the affordable monitoring of the safety of cannabis products, including those used recreationally and as a food supplement."
This self-paced four-week University of Washington course is designed to help learners "gain an overview of the cybersecurity landscape as well as national (USA) and international perspectives on the field." The course is free to take and requires on average two to five hours a week of effort.